Drugs / Inactivated Trivalent Influenza Vaccine
Inactivated Trivalent Influenza Vaccine
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03784885 | Sep 2017 → Jan 2018 | influenza | Advagene Biopharma Co. Ltd. | Completed | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT02762851 | Jun 2016 → Dec 2019 | heart failure, influenza | McMaster University | Unknown | No outcome recorded |
| Phase 4 | NCT01945268 | Apr → Dec 2015 | heart failure | McMaster University | Completed | No outcome recorded |
| Phase 4 | NCT01680679 | May 2012 → May 2014 | influenza | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 4 | NCT00934245 | Sep 2009 → Jul 2012 | influenza | Wayne Sullender, M.D. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01713855 | Oct 2004 → Mar 2006 | autoimmune thrombocytopenic purpura | Neufeld, Ellis J, MD, PhD | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05895955 Comparator | Nov 2023 → Mar 2024 overdue | influenza | Mahidol University | Active not recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00479648 Comparator | May → Aug 2007 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Trivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01680679 ↗ |
| Known as | IIV3 | “trivalent inactivated influenza vaccine (IIV3)” PMID 31200893 ↗ Jul 2019 |
| Known as | TIV | “Inactivated split virion trivalent influenza vaccine (TIV)” NCT00934245 ↗1“Inactivated Trivalent Influenza Vaccine (TIV)” NCT01680679 ↗ |
| Known as | trivalent inactivated influenza vaccine | “trivalent inactivated influenza vaccine (IIV3)” PMID 31200893 ↗ Jul 2019 |
| Known as | Vaxigrip vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05895955 ↗ |
| Modality | Vaccine | “Inactivated trivalent influenza vaccine” NCT00479648 ↗ |
| Route | Intramuscular | “intramuscular trivalent inactivated influenza vaccine (IIV3)” PMID 31200893 ↗ Jul 2019 |